N4 Pharma collaborates with SRI International to combine Nuvec and FOX Three MGS technology
N4 Pharma Plc partners with SRI International to combine Nuvec® with FOX Three MGS, aiming to enhance nucleotide therapies for cancer and vaccines.
Stay updated with breaking news from Bioscience Division. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
N4 Pharma Plc partners with SRI International to combine Nuvec® with FOX Three MGS, aiming to enhance nucleotide therapies for cancer and vaccines.
Investegate announcements from Collaboration Agreement with SRI International Inc
Tosoh Corporation has announced it will increase the production capacity of separation and purification media TOYOPEARL®and TSKgel® PW at its Nanyo Complex (Shunan City, Yamaguchi Prefecture) in response to
(Page 1) Tosoh Corp. (Tokyo) has announced it will increase the production capacity of separation and purification media TOYOPEARL and TSKgel PW at its Nanyo
Grifols (NASDAQ:GRFS – Get Rating) was downgraded by Zacks Investment Research from a “hold” rating to a “sell” rating in a report released on Wednesday, Zacks.com reports. According to Zacks, “Grifols, S.A., operates in the pharmaceutical-hospital sector engaged in the research, development and retailing of plasma derivates, products for intravenous therapy, clinical nutrition, diagnostic and […]